Developing a Malaria Vaccine


HJFMRI supports the Kenya Medical Research Institute (KEMRI) in clinical research to test and advance malaria vaccines.

Most recently, the Mal 094 study was conducted in Western Kenya as a Phase 2b trial to study the efficacy, safety and immunogenicity of the world’s first malaria vaccine, RTS,S/AS01E. HJFMRI provided day-to-day research operations support for this malaria vaccine research and ensured safe, uninterrupted continuance of research in the face of COVID-related challenges and restrictions.